بررسی تأثیر روغن گلمغربی بر طول مدت اندوه پس از زایمان در زنان نخستزا: یک کارآزمایی بالینی دوسوکور کنترل شده

نوع مقاله: اصیل پژوهشی

نویسندگان

1 کارشناس ارشد مامایی، دانشکده پزشکی، دانشگاه علوم پزشکی جندی شاپور اهواز، اهواز، ایران.

2 کارشناس ارشد روانشناسی، دانشگاه علوم پزشکی جندی شاپور اهواز، اهواز، ایران.

3 کارشناس ارشد مامایی، دانشکده علوم پزشکی شوشتر، شوشتر، ایران.

چکیده

مقدمه: از آنجایی که در تحقیقات­ مختلف بین سطح ­امگا-3 و خلق ­افسرده ارتباط وجود دارد و روغن گل­مغربی از منابع غنی امگا-3 می­باشد، مطالعه حاضر با هدف بررسی تأثیر روغن گل­ مغربی بر طول­ مدت اندوه پس از زایمان زنان انجام شد.
روش‌کار: این مطالعه کارآزمایی بالینی دوسوکور در سال 92-1391 بر روی 132 نفر از زنان باردار نخست­زای مراجعه­کننده به مراکز بهداشتی اهواز صورت گرفت. افراد در دو گروه 66 نفری جهت دریافت روزانه یک­گرم کپسول روغن گل­ مغربی (گروه مداخله) و کپسول ژلاتینی خوراکی مشابه (گروه کنترل) از آغاز هفته 37 بارداری تا 2 هفته پس از زایمان قرار گرفتند. نمونه­ها در روزهای 4، 10 و 14 پس از زایمان با آزمون استاندارد ادینبرگ بررسی شدند. تجزیه و تحلیل داده­ها با استفاده از نرم‌افزار آماری  SPSS(نسخه 20) و آزمون‌های آماری تی­مستقل، کای­اسکوئر و آنالیز مقادیر تکراری انجام شد. میزان p کمتر از 05/0 معنی­دار در نظر گرفته شد.
یافته­ها: بین طول مدت اندوه پس از زایمان دو گروه اختلاف آماری معنی­داری وجود داشت؛ به‌طوری‌که طول مدت اندوه پس از زایمان در گروه مداخله کمتر از گروه پلاسبو بود (004/0=p). میانگین نمره آزمون ادینبرگ به‌طور معنی‌داری در گروه مداخله نسبت به گروه کنترل در روز چهارم (0001/0=p)، دهم (001/0=p) و چهاردهم (08/0=p) پس از زایمان کمتر بود.
نتیجه­گیری: مصرف روغن گل مغربی در کاهش طول ­مدت اندوه پس از زایمان مؤثر است.

کلیدواژه‌ها


عنوان مقاله [English]

The effect of evening primrose oil on duration of postpartum blues among primiparous women: a double-blind, randomized controlled clinical trial

نویسندگان [English]

  • Soghra Nikoomazhab 1
  • Mohammad Reza Haghdoust 2
  • Azam Honarmandpour 3
1 M.Sc. of Midwifery, Faculty of Medicine, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.
2 M.Sc. of Psychology, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.
3 M.Sc. of Midwifery, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran
چکیده [English]

Introduction: Since there are relationship between omega-3 and depressed mood in different studies, and Evening primrose oil is rich of omega, this study was performed with aim to evaluate the effect of evening primrose oil on duration of postpartum blues among primiparous women.
Methods: This double-blind randomized controlled trial was conducted in 2012-2013 on 132 primiparous women referred to health centers of Ahvaz. The subjects were randomly divided into two groups of 66 cases to receive a daily dose of 1 gr of evening primrose oil capsule (intervention group) or similar oral gelatin capsule (control group) from the beginning of the 37th weeks of pregnancy up to two weeks postpartum. The samples were assessed by Edinburg standard test on days 4, 10 and 14th postpartum. Data were analyzed using SPSS software (version 20), and statistical tests of independent t, Chi-square and repeated measures analysis tests. P Results: There was statistically significant difference between two groups regarding the duration of postpartum blues, so that the duration of postpartum blues in the intervention group was less than the placebo group (p=0.004). The mean of score Edinburgh test in the intervention group was significantly less compared to the control group on the 4th day (p = 0.0001), 10th day (p = 0.001) and 14th day postpartum (p = 0.08).
Conclusion: The use of evening primrose oil is effective in reducing the duration of postpartum blues.

کلیدواژه‌ها [English]

  • Evening Primrose Oil
  • Postpartum
  • Primiparous
  • Women
  1. Glangeaud-Freudenthal NC, Crost M, Kaminski M. Sever post-delivery blues: associated factors. Arch Womens Ment Health 1999; 2(1):37-44.
  2. Brockington I. Postpartum psychiatric disorders. Lancet 2004; 363(9405):303-10.
  3. Henshaw C. Mood disturbance in the early puerperium. Arch Womens Ment Health 2003; 6(2):33-42.
  4. Cunningham G, Leveno K, Bloom S, Spong C, Dashe J, Hoffman B, et al. Williams Obstetrics. 24th ed. New York: McGraw Hill; 2014. P. 1488-9.
  5. Held L, Rutherford A. Can't a mother sing the blues? Postpartum depression and the construction of motherhood in late 20th-century America. Hist Psychol 2012; 15(2):107-23.
  6. Ricci SS. Essentials of maternity, newborn and woman's health nursing. Philadelphia: Lippincott Williams and Wikins; 2006.
  7. Gonidakis F, Rabavilas AD, Varsou E, Kreatsas G, Christodoulou GN. Maternity blues in Athens, Greece: a study during the first 3 days after delivery. J Affect Disord 2007; 99(1):107-15.
  8. Adewuya AO. The maternity blues in western Nigerian women: prevalence and risk factors. Am J Obstet Gynecol 2006; 193(4):1522-5.
  9. Hau FW, Levy VA. The maternity blues and Hong Kong Chinese women: an exploratory study. J Affect Disord 2003; 75(2):197-203.
  10. Moslemi L. Prevalence of postpartum blues. [Master Thesis]. Ahvaz, Iran: Jundishapur University Medical Sciences; 2007. (Persian).
  11. O’Keane V, Lightman S, Patrick K, Marsh M, Papadopoulos AS, Pawlby S, et al. Changes in the maternal hypothalamic-pituitary-adrenal axis during the early puerperium may be related to the postpartum 'blues'. J Neuroendocrinol 2011; 23(11):1149-55.
  12. Buttner MM, O'Hara MW, Watson D. The structure of women's mood in the early postpartum. Assessment 2012; 19(2):247-56.
  13. Adewuya AO. The maternity blues in western Nigerian women; prevalence and risk factors. Am J Obstet Gynecol 2005; 193(4):1522-5.
  14. Janati Yadalalah KN. Psychiatric in nursing. Tehran: Community Oriented; 2005. (Persian).
  15. Desari AK, Grossberge GT. Herbal and botanicals in geriatric psychiatry. Am J Geriater Psychiatry 2003; 11(5):498-506.
  16. Kamalipour M, Akhoundzadeh SH, Rezazadeh S. Herbal medicines in the treatment of depression and anxiety. J Med Planets 2008; 7(4):1-7. (Persian).
  17. Grenyer BF, Crowe T, Meyer B, Owen AJ, Grigonis-Deane EM, Caputi P, et al. Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(7):1393-6.
  18. Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M. Placebo controlled continuation treatment with Hypericum extract WS 5570 after recovery from a mild or moderate depressive episode. Wien Med Wochenschr 2007; 157(13-14):362-6.
  19. Ghasemnezhad A, Honermeier B. Yield, oil constituents, and protein content of evening primrose (Oenothera biennis L.) seeds depending on harvest time, harvest method and nitrogen application. Indust Crops Prod 2008; 28(1):17-23. (Persian).
  20. Borja-Hart NL, Marinoy J. Role of omega-3 fatty acids for prevention or treatment of prenatal depression. J Hum Pharmacol Ther 2010; 30(2):210-6.
  21. Hibbeln JR, Salem N. Dietary polyunsaturated fats and depression: when cholesterol alone doesn’t satisfy. Am J Clin Nutr 1995; 62:1-9.
  22. Saki M, Jariani M, Saki K, Delfan B, Tarahi M, Gholami M. Effects of evening primrose oil on depression disorders on patients at the psycho-neurological clinic of Khoramabad. J Ilam Univ Med Sci 2008; 16(4):47-56. (Persian).
  23. Lin PY, Su KP. A meta-analytic review of double blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 2007; 68(7):1056-61.
  24. Logan AC. Omega–3 fatty acid and major depression: a primer for the mental health professional. Lipids Health Dis 2004; 3:25.
  25. Logan AC. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev 2003; 8(4):410-25.
  26. Liorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC, Heird WC. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 2003; 188(5):1348-53.
  27. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002; 159(3):477-9.
  28. Nemetes H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omege-3 treatment of childhood depression: a controlled double-blind pilot study. Am J Psychiatry 2006; 163(6):1098-100.
  29. Coates PM, Blackman M, Betz JM, Cragg GM, Levine MA, Moss J, et al. Encyclopedia of dietary supplements. New York: Marcel Dekker; 2005.
  30. Braun L, Cohen M. Herbs and natural supplements: an evidence-based guide. London: Churchill Livingstone; 2010.
  31. Bayles B, Usatine R. Evening primrose oil. Am Fam Physician 2009; 80(12):1405-8.
  32. Blommers J, de Lange-De Klerk ES, Kuik DJ, Bezemer PD, Meijer S. Evening primrose for severe chronic mastalgia: a randomized, double- blind, controlled trial. Am J Obstet Gynecol 2002; 187(5):1389-94.
  33. da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, et al. Depression in Parkinson’s disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J Affect Disord 2008; 111(2-3):351-9.
  34. Wang W, Chen HS, Liu JP. Evening primrose oil or other essential fatty acids for the treatment of pre-menstrual syndrome (PMS). New York: John Wiley & Sons; 2009.
  35. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale--preliminary report. Psychopharmacol Bull 1973; 9(1):13-28.
  36. Najarian B, Davoudi I. Construction and validation of short form for SCL-90-r (SCL-25). J Psychol 2001; 5(2):136-49. (Persian).
  37. Goldberg DP, Hillier VF. A scaled version of general health questionnaire. Psychol Med 1979; 9(1):131-45.
  38. Ebadi M, Harirchi A-M, Shariati M, Gormoodi GhR-, Fateh A, Montazeri A .Translation, Determining the Reliability and Validity of General Health Questionnaire (GHQ). 2002; 1 (3): 39-46.
  39. Dennis CL. Can we identify mothers at risk for postpartum depression in the immediate postpartum period using the Edinburgh postnatal depression scale. J Affect Disord 2004; 78(2):163-9.
  40. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998; 48(2-3):149-55.
  41. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 2006; 163(3):1098-100.
  42. Sublette ME, Hibbelen JR, Galfalvy H, Oquendo MA, Mann J. Omega3 polyunsaturated, essential fatty acid status as a predictor of future suicide risk. Am J psychiatry 2006; 163(6):1100-2.
  43. Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acid in major depressive disorder a preliminary double blind Placebo controlled trial. Eur Neuropsychophamacol 2003; 13(4):267-71.
  44. Momeni H, Salehi A, Seraji A. The comparison of Vitex agnus castus and evening primrose oil on women’s depression: a clinical trial. Yafte 2013; 15(2):67-76. (Persian).
  45. Saki M, Jariani M, Saki K, Delfan B, Tarahi M, Gholami M. Effects of evening primrose oil on depression disorders on patients at the psycho-neurological clinic of Khoramabad. J Ilam Univ Med Sci 2008; 16(4):47-56. (Persian).
  46. Ivanbaga R, Norousi Panahi L, Ghojazadeh M, Ranjbar Koochaksaraee F. Comparison of effectiveness of Omega-3 Fatty Acids with placebo in treatment of mild to moderate postpartum depression. J Ardabil Univ Med Sci 2009; 9(1):23-32. (Persian).
  47. Nahidi F, Taghizadeh S, Sadr S, Alavi Majd H. The effect of omega-3 fatty acids on postpartum depression. Iran J Obstet Gynecol Infertil 2011; 14(7):24-31. (Persian).
  48. Su KP, Huang SY, Chiu CC, Shen WW. Omega- 3 fatty acid in major depressive disorder a preliminary double blind Placebo controlled trial. Eur Neuropsychophamacol 2003; 13(4):267-71.
  49. Klerman GL, Weissman MM. Increasing rates of depression. JAMA 1989; 261(15):2229-35.